These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 16140364)

  • 1. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
    Taylor DH; Ostermann J; Van Houtven CH; Tulsky JA; Steinhauser K
    Soc Sci Med; 2007 Oct; 65(7):1466-78. PubMed ID: 17600605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
    Oestreicher N; Ramsey SD; McCune JS; Linden HM; Veenstra DL
    Cancer; 2005 Nov; 104(10):2054-62. PubMed ID: 16216002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.
    Miller SC; Intrator O; Gozalo P; Roy J; Barber J; Mor V
    J Am Geriatr Soc; 2004 Aug; 52(8):1284-92. PubMed ID: 15271115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.
    Goodridge D; Lawson J; Duggleby W; Marciniuk D; Rennie D; Stang M
    Respir Med; 2008 Jun; 102(6):885-91. PubMed ID: 18313278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?
    Dalrymple JL; Levenback C; Wolf JK; Bodurka DC; Garcia M; Gershenson DM
    Gynecol Oncol; 2002 May; 85(2):356-61. PubMed ID: 11972400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative charge analysis of one- and two-level lumbar total disc arthroplasty versus circumferential lumbar fusion.
    Levin DA; Bendo JA; Quirno M; Errico T; Goldstein J; Spivak J
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2905-9. PubMed ID: 18246016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking care of terminally-ill patients at home - the economic perspective revisited.
    Tamir O; Singer Y; Shvartzman P
    Palliat Med; 2007 Sep; 21(6):537-41. PubMed ID: 17846094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
    Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.
    Hoekstra A; Singh DK; Garb M; Arekapudi S; Rademaker A; Lurain JR
    Gynecol Oncol; 2006 Dec; 103(3):897-901. PubMed ID: 16814370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utilization of palliative care in gynecologic oncology patients near the end of life.
    Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
    Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis.
    Aletti GD; Podratz KC; Moriarty JP; Cliby WA; Long KH
    Gynecol Oncol; 2009 Jan; 112(1):16-21. PubMed ID: 19027146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
    Bercovitch M; Adunsky A
    Cancer; 2004 Sep; 101(6):1473-7. PubMed ID: 15368335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospice and emergency room use by disadvantaged men dying of prostate cancer.
    Bergman J; Kwan L; Fink A; Connor SE; Litwin MS
    J Urol; 2009 May; 181(5):2084-9. PubMed ID: 19286207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The end of life costs for Medicare patients with advanced ovarian cancer.
    Urban RR; He H; Alfonso R; Hardesty MM; Goff BA
    Gynecol Oncol; 2018 Feb; 148(2):336-341. PubMed ID: 29208368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.